The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study
Introduction: Increased galectin-3 is associated with ischemic cardiomyopathy, although its role in early remodeling post-myocardial infarction (MI) has not been fully elucidated. There are no data demonstrating that blocking galectin-3 expression would have an impact on the heart and that its relat...
Main Authors: | Wassim Mosleh, Milind R Chaudhari, Swati Sonkawade, Supriya Mahajan, Charl Khalil, Kevin Frodey, Tanvi Shah, Suraj Dahal, Roshan Karki, Rujuta Katkar, W Matthijs Blankesteijn, Brian Page, Saraswati Pokharel, Minhyung Kim, Umesh C Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-05-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/1177271918771969 |
Similar Items
-
Galectin-1 in early acute myocardial infarction.
by: Suhail Al-Salam, et al.
Published: (2014-01-01) -
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction
by: Giulia Gagno, et al.
Published: (2019-04-01) -
Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
by: Victoria Karetnikova, et al.
Published: (2016-01-01) -
Galectin-3: A Cardiomyocyte Antiapoptotic Mediator at 24-Hour Post Myocardial Infarction
by: Suhail Al-Salam, et al.
Published: (2020-04-01) -
Correlation between Galectin-3 and Adverse Outcomes in Myocardial Infarction Patients: A Meta-Analysis
by: Lei Tian, et al.
Published: (2020-01-01)